Navigation Links
SAFC Appoints New Vice President of Quality and Regulatory Affairs
Date:8/4/2008

ST. LOUIS, Mo., Aug. 5 /PRNewswire-FirstCall/ -- SAFC(R), a member of the Sigma-Aldrich Group (Nasdaq: SIAL), today announced the appointment of Mr. Tom Beil as Vice President of Quality and Regulatory Affairs, effective July 21, 2008. Mr. Beil, a quality systems and operations professional with nearly 25 years experience, will lead SAFC's robust quality assurance team and oversee all aspects of the Company's regulatory and quality assurance programs. He will report to SAFC President, Dr. Frank Wicks, and to Mr. Rich Keffer, General Counsel and Secretary for Sigma-Aldrich(R) Corporation. This appointment is Mr. Beil's second tenure with Sigma-Aldrich, having spent 13 years as Quality Systems Manager from 1986 to 1999.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080805/AQTU008)

Citing the ever-increasing importance that transparency, quality assurance and regulatory compliance play in the pharmaceutical development and manufacturing supply chain, Dr. Wicks states, "We are pleased to welcome Tom back to SAFC. He brings a wealth of knowledge and experience that is expected to help us continue to build upon our industry-leading regulatory compliance position. His addition to our senior management team will be focused on helping us support risk mitigation, quality assurance and regulatory initiatives across our product and service lines and will enhance the regulatory partnerships we intend to build with our customers to guide them through the challenges they face in procuring materials with the proper compliance profiles."

Mr. Beil joins SAFC from Centocor/GBSC, where he was Senior Director of Site Quality with responsibilities for quality assurance, quality control and quality systems. Prior to that appointment, Mr. Beil worked as Associate Director of Quality Assurance for Wyeth. In addition to his in-depth knowledge of quality systems and the regulatory environment, he has experience in petrochemical chemistry, research biology, cell culture and purchasing, and holds a Masters degree in Biology from Illinois State University at Normal, Illinois.

About SAFC: SAFC(R) is the custom manufacturing and services group within Sigma-Aldrich that focuses on high-purity inorganics for high technology applications, cell culture products and services for biopharmaceutical manufacturing, biochemical production and the manufacturing of complex, multi-step organic synthesis of APIs and key intermediates. SAFC has manufacturing facilities around the world dedicated to providing manufacturing services for companies requiring a reliable partner to produce their custom manufactured materials. SAFC has four focus areas -- SAFC Pharma(TM), SAFC Supply Solutions(R), SAFC Biosciences(TM), and SAFC Hitech(TM) -- and had annual sales of nearly $600 million in 2007. SAFC is one of the world's 10 largest fine chemical businesses. For more information about SAFC, visit http://www.safcglobal.com.

About Sigma-Aldrich: Sigma-Aldrich: is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 36 countries and has 8,000 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at http://www.sigma-aldrich.com.

SAFC(R), SAFC Supply Solutions(R) and Sigma-Aldrich(R) are registered trademarks and SAFC Pharma(TM), SAFC Biosciences(TM) and SAFC Hitech(TM) are trademarks of Sigma-Aldrich Biotechnology L.P. and Sigma-Aldrich Co.


'/>"/>
SOURCE Sigma-Aldrich Group
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Anacor Pharmaceuticals Appoints Dr. Kurt Jarnagin Vice President of Biological Research
2. ARCA biopharma Appoints James Carr as Vice President of Marketing
3. China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors
4. Health Monitoring Systems Appoints Karen S. Dockrell As VP, Sales
5. Human Genome Sciences Appoints David P. Southwell to its Board of Directors
6. Tengion Appoints Mark Stejbach Vice President of Marketing & Commercial Planning
7. Innocoll Appoints Anthony H. Wild Ph.D. to Its Board of Directors
8. AMT Appoints Director Global Marketing and Sales
9. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
10. WuXi PharmaTech (NYSE: WX) Appoints Dr. Debra Yu as VP of Strategy
11. PharmAthene Appoints Jordan P. Karp, J.D. Senior Vice President and General Counsel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... The Academy of Model ... University Aviation Association (UAA), the unifying voice for collegiate aviation education, are launching ... teamwork, competition, and success through a STEM-based education platform. , Much like the ...
(Date:6/22/2017)... Colorado (PRWEB) , ... June 21, 2017 , ... ... RTP regional office in North Carolina, and engages Timothy Reinhardt to manage the ... of quality leadership at Pfizer Inc, with his most recent role as the ...
(Date:6/22/2017)... Germany (PRWEB) , ... June 22, 2017 , ... ... is taking over the allergy specialists DST Diagnostische Systeme & Technologien GmbH, thereby ... all know someone who suffers from hay fever, urticaria, asthma, atopic eczema or ...
(Date:6/22/2017)... ... June 22, 2017 , ... For the months ... produced a Spotlight series on “Cell Therapy Regulation” for its regenerative ... experts on the unique regulatory challenges of stem cell medical research. , Stem ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
(Date:3/24/2017)... , Mar 24, 2017 Research and ... Access System Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 15.1% over the next ... This industry report analyzes the market estimates and forecasts for all ...
Breaking Biology News(10 mins):